PMA device
WaveWriter Alpha and WaveWriter Alpha Prime SCS Systems
Boston Scientific Corp · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Dec 1, 2020, newest Sep 9, 2026Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
4
Naming "WaveWriter Alpha"
MAUDE reports
10,641
Brand "WaveWriter Alpha", since 2015
PubMed studies
1
Mentioning "WaveWriter Alpha"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing WaveWriter Alpha and WaveWriter Alpha Prime SCS Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- WaveWriter Alpha and WaveWriter Alpha Prime SCS Systems; Celestia and Celestia Prime SCS SystemsPMA supplement
P030017-S396 · Decided Sep 9, 2026 · 90 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- WaveWriter Alpha Spinal Cord Stimulator (SCS) SystemPMA supplement
P030017-S338 · Decided Dec 1, 2020 · 222 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "WaveWriter Alpha", any status and sponsor, newest update first.
Nantes University HospitalAcademic, hospital or other
NCT05398003 · 12 participants (planned) · Start Nov 23, 2022 · Primary completion Sep 23, 2027
Device: Implantation of the WAVEWRITER ALPHA ™ device · For: Pain, Intractable
Sites: Nantes, France
- Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current ControlRecruiting
Boston Scientific CorporationPublic (BSX)
NCT07190807 · 70 participants (planned) · Start Nov 7, 2025 · Primary completion Nov 2027
Device: Boston Scientific WaveWriter Alpha™ SCS Systems · For: Chronic Pain; Intractable Pain; Low Back Pain and 3 more
Sites: Greenwood, Colorado; Clermont, Florida; New Orleans, Louisiana · 7 sites in all
Ecole Polytechnique Fédérale de LausanneAcademic, hospital or other
NCT06845904 · 3 participants (planned) · Start Mar 10, 2025 · Primary completion Feb 2027
Device: WaveWriter Alpha™ neurostimulation system · For: Spinal Cord Injuries (SCI); Spinal Cord Injury
Sites: Lausanne, Switzerland
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "WaveWriter Alpha", and for the whole product code for context.
This brand
10,641 reports: 164 malfunction, 10,332 injury, 144 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
- WaveWriter Alpha? PrimeInjury
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-08314 · Received Oct 30, 2026 · Event dated Oct 5, 2026
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Battery Problem; Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- WaveWriter Alpha?Injury
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-08322 · Received Oct 30, 2026 · Event dated May 5, 2026
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Discomfort; Implant Pain; Tissue Irritation
- WaveWriter Alpha?Injury
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-08324 · Received Oct 30, 2026 · Event dated Oct 12, 2026
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Fever; Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2879-2026 · Started Jun 17, 2026 · Posted by FDA Aug 5, 2026
Reason given: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
- Boston Scientific Model SC-4318, Clik X Anchor REF: M365SC43180Open, Classified
Boston Scientific Neuromodulation Corporation
Z-2404-2026 · Started Apr 29, 2026 · Posted by FDA Jun 11, 2026
Reason given: Sterile anchors my lack sterility assurance.
Cause as FDA categorized it: Packaging process control · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
- WAVEWRITER ALPHA: Model: SC-1216, 16 IPG KIT, REF: M365SC12160; Model: SC-1232, 32 IPG KIT, REF: M365SC12320Open, Classified
Boston Scientific Neuromodulation Corporation
Z-2617-2024 · Started Jul 17, 2024 · Posted by FDA Aug 14, 2024
Reason given: Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset, which may lead to transient loss of stimulation; patients may experience undesired sensations when therapy turns off for approx. 10-15 seconds and then back on, which...
Cause as FDA categorized it: Software design · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
14 more recall records with a free account
Published research
The most relevant PubMed records for "WaveWriter Alpha"[tiab]. The summary above synthesizes these.
- Automated Neural Dosing for Fast-Acting Subperception Therapy: Sustained Spinal Cord Stimulation Outcomes from a Multicenter Study.
Ferro R, North J, Kranenburg A, et al. · Pain Ther · 2025
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Senza Spinal Cord Stimulation (SCS) SystemNevro Corporation · PMA 2025
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.